With the stock near a 5-year low, is it worth a look?
News
High-signal headlines only - macro events, earnings, M&A, regulatory. Listicles and analyst clickbait filtered out by default. Refreshed hourly.
The crypto exchange is taking share of a shrinking market -- and the loss is getting smaller each quarter.
July doesn't seem likely to end on a happy note for this specialty chemicals stock.
Moby summary of WisdomTree, Inc.'s Q2 2026 earnings call
Moby summary of Oxford Square Capital Corp.'s Q2 2026 earnings call

<body><p>STORY: :: Recorded on July 31</p><p>:: Lisa Bernhard, Reuters</p><p>:: Dean Smith, Portfolio Manager, FolioBeyond</p><p>Shares of Apple tumbled as much as 10% on Friday after a disappointing forecast showed that the iPhone maker was struggling to secure enough components as the AI-driven data center boom strains global supply chains.</p><p>The drop, if sustained, would erase nearly $500 billion from Apple's market capitalization and return the crown of the world's most valuable company to AI chip giant Nvidia, days after reclaiming it.</p><p>Meanwhile, shares of Amazon soared as much as 15% after the tech giant's solid cloud sales growth reinforced investor confidence in its massive AI bets.</p><p>"There's two really different trends going on," said Smith. "One is the hardware constraint, the [other is] cloud compute capacity, and those are going to continue to drive what we see in the AI investment thesis."</p><p>Next week, the focus will remain on AI when SpaceX delivers its first quarterly earnings results since going public.</p><p>"There's no mystery about how many rockets they're firing off, we can see them," said Dean with a laugh. "So what I'm looking for in SpaceX is to see what is their plan for the AI side of the business."</p></body>
Moby summary of Balchem Corporation's Q2 2026 earnings call
Retailers could receive an unexpected financial windfall.
Moby summary of Chevron Corporation's Q2 2026 earnings call
Amazon raised planned capital expenditure to $220 billion and reaffirmed NVIDIA's importance despite developing its own Trainium processors.
Key takeawaysMoonshot AI reportedly accesses roughly 20,000 Nvidia chips through a computing agreement with Alibaba Group. The Hopper-generation cluster provides a significant portion of the computing capacity behind Moonshot’s Kimi models.
Moonshot reportedly gained access to computing capacity equal to about 20,000 Nvidia chips.
Micron is crushing the market now, but Wall Street wonders how long it will last.
Samsung and SK Hynix produced their largest recorded gains as investors returned to Korean semiconductor stocks after a severe July selloff.
Pull up a chair; it could be a long wait before SpaceX stock looks like a good buy.
There is more to this stock than meets the eye.
Nano Nuclear Energy is riding a wave of good news.
Morningstar described NVIDIA as undervalued after its pullback, while retaining a very-high uncertainty assessment.
Amazon delivered blockbuster results across the board.
Is the ride-hailing underdog still a reliable investment?
Google and Amazon both claim their custom chips can replace Nvidia, but they built completely opposite silicon strategies to get there. Which approach actually holds up when the free cash flow bills come due?
The landmark deal between NuScale, ENTRA1, and TVA could be NuScale's first big deal, but read the fine print.
Memory stocks have been brutal lately, but not all of them are hurting equally, and the gap between the winners and losers may tell investors exactly where to put their money next.
The e-commerce service provider has a lot to prove.
SpaceX (NASDAQ:SPCX) stock is down 36% over the past month, leaving investors who bought near the post-IPO peak with steep losses. The selloff has sparked a natural question: would switching into other space names like Rocket Lab (NASDAQ:RKLB) or AST SpaceMobile (NASDAQ:ASTS) offer a safer path forward? The short answer is not necessarily. Rocket Lab ... SpaceX Is Now Down 36% in a Month. Would You Be Better Off With Rocket Lab or ASTS SpaceMobile?
Taiwan Semiconductor just posted one of the strongest earnings reports in chip-stock history, yet the stock sits 15% below its all-time high. Three specific catalysts could send it to a price Wall Street has not fully priced in yet.
In the U.S., regulation can protect incumbents while discouraging entrepreneurs. China gives fast-moving startups room to grow before exerting state control.
The global market for obesity drugs is soaring, yet Lilly has a dominant market share.